Gross Margin
22.93%vs Specialty Chemicals peers Updated Aug 8, 2026Profit Margin
4.92%vs Specialty Chemicals peers Updated Aug 8, 2026Operating Margin
10.34%vs Specialty Chemicals peers Updated Aug 8, 2026Return on Assets (TTM)
3.00%vs Specialty Chemicals peers Updated Aug 8, 2026Return on Equity (TTM)
7.32%vs Specialty Chemicals peers Updated Aug 8, 2026Revenue (TTM)
4.53BCNY670.96M · vs all stocks (USD) Updated Aug 8, 2026Revenue per Share (TTM)
8.17CNYUpdated Aug 8, 2026Quarterly Revenue Growth
8.60%vs Specialty Chemicals peers Updated Aug 8, 2026Gross Profit (TTM)
1.06BCNY157.41M · vs all stocks (USD) Updated Aug 8, 2026EBITDA (TTM)
401.44MCNY59.49M · vs all stocks (USD) Updated Aug 8, 2026Net Income (TTM)
222.88MCNY33.03M · vs all stocks (USD) Updated Aug 8, 2026Quarterly Earnings Growth (YoY)
2.80%vs Specialty Chemicals peers Updated Aug 8, 2026Operating Cash Flow (TTM)
252.16MCNY37.37M · vs all stocks (USD) Updated Aug 8, 2026Levered Free Cash Flow (TTM)
595.83MCNY88.30M · vs all stocks (USD) Updated Aug 8, 2026Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 8, 2026Trailing Annual Dividend Yield
1.35%Updated Aug 8, 20265-Year Average Dividend Yield
2.29%Updated Aug 8, 2026Payout Ratio
37.53%vs Specialty Chemicals peers Updated Aug 8, 2026Minority Interest (Equity)
89.87MCNYFY2025 · Dec 31, 2025Revenue
4.44BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.39BCNYFY2025 · Dec 31, 2025Gross Profit
1.05BCNYFY2025 · Dec 31, 2025Operating Income
363.06MCNY53.80M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
272.46MCNYFY2025 · Dec 31, 2025Income Tax Expense
46.28MCNYFY2025 · Dec 31, 2025Net Income
226.18MCNYFY2025 · Dec 31, 2025EBIT
334.27MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
545.06MCNYFY2025 · Dec 31, 2025Research & Development
213.53MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
193.29MCNYFY2025 · Dec 31, 2025Other Operating Expenses
28.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.59MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
61.81MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3979CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3961CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
554.39MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
554.39MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
226.18MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-5.59MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-60.63MCNYFY2025 · Dec 31, 2025Free Cash Flow
-244.61MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
732.51MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
226.18MCNYFY2025 · Dec 31, 2025Other Non-cash Items
62.88MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-409.11MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
59.41MCNYFY2025 · Dec 31, 2025Capital Expenditures
-183.98MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.43BCNYFY2025 · Dec 31, 2025Sale of Investments
2.63BCNYFY2025 · Dec 31, 2025Other Investing Activity
4.41MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
20.31MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.01BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.04BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-131.05MCNYFY2025 · Dec 31, 2025Other Financing Charges
6.52MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-148.74MCNYFY2025 · Dec 31, 2025